Free Access to FDA 483s
Many people in the pharmaceutical industry are aware of the fact that Warning Letters issued by the US Food and Drug Administration (FDA) are published on the FDA website.
But the Office of Regulatory Affaires (ORA) is also publishing other copies of ORA domestic inspection and related records. This is done either proactively at ORA's discretion or because they are "frequently requested" per the Electronic Freedom of Information Act Amendments of 1996.
Here is an overview on what is available:
- 483 observations are best to be seen at the "frequently requested or proactively posted compliance records" site
- Enforcement Reports, Recalls, Import Alerts, Import Refusals etc. can be found at the data sets page
- Warning Letters are accessible on a dedicated page for Warning Letters
- Establishment Inspection Reports can be searched in the ORA FOIA Electronic Reading Room
- Persons currently debarred pursuant to sections 306(a) or (b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 335(a) or (b) are listed in the FDA Debarment list
- Other ORA documents cab be found on the ORA home page.
Related GMP News
24.07.2024FDA Warning Letter to a Manufacturer of an Athlete Muscle Maintenance Creme
24.07.2024FDA describes detailed CAPA Procedure in Warning Letter
17.07.2024Congressional Scrutiny on FDA's Foreign Inspection Program puts Pressure on Agency
19.06.2024More FDA Inspections again - also in the EU?
12.06.2024GMP Problems with critical Medicinal Products - what now?
15.05.2024Lack of Quality Oversight: EU Non-Compliance Report issued to Omeprazole Manufacturer